CTEVClaritev Corporation
What is the market doing?
Rangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Rangebound, no clear trend. Price is −9% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CTEV is trading
Claritev Corporation is −56% over the past year while the S&P 500 is +18%: 74 points behind the market. Through the fall, its own insiders bought $493K more stock than they sold.
1-year return · S&P 500 +18%
- vs 200-day average
- −8.7%
vs 200-day average · below trend, but not far
- RSI (14)
- 30
RSI (14) · neutral
- Below its 52-week high
- 66%
Below its 52-week high
Details›
- Last close2026-10-08
- $24.38
- 1 monthS&P 500 +1.6%
- −33%
- 1 yearS&P 500 +18%
- −56%
- 5 yearsS&P 500 +86%
- −89%
- vs 50-day average$31.70
- −23%
- 52-week high
- $71.36
- 52-week low
- $13.47
- Annualised volatility
- 133%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $493K
| Year | Return |
|---|---|
| 2026 (year to date) | −43% |
| 2025 | +189% |
| 2024 | −74% |
| 2023 | +25% |
| 2022 | −74% |
| 2021 | −45% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 2 of 6 | −6.2% |
| Feb | 6 | 2 of 6 | −11% |
| Mar | 6 | 3 of 6 | −0.09% |
| Apr | 6 | 3 of 6 | +9.8% |
| May | 7 | 6 of 7 | +18% |
| Jun | 7 | 6 of 7 | +15% |
| Jul | 7 | 2 of 7 | −7.8% |
| Aug | 7 | 3 of 7 | +5.1% |
| Sep | 7 | 0 of 7 | −18% |
| Oct | 7 | 5 of 7 | +0.54% |
| Nov | 6 | 0 of 6 | −19% |
| Dec | 6 | 4 of 6 | +13% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Health Information Services
Ranks #12 of 20 by RyuScore